Highlights Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 16:00:02 2025-12-16 EST			5-day change	1st Jan Change
219.30 ^USD	-0.36%		-5.47%	+4.30%

12-12	Rate Cuts Can't Buy Confidence
12-12	KeyBanc Downgrades Veeva Systems to Sector Weight From Overweight, Removes $325 Price Target	MT

Highlights

UiPath Joins the Veeva AI Partner Program to Deliver Secure & Trusted Agentic Testing Capabilities for Quality Management	12-04	CI
Veeva Systems Announces the Availability of Veeva Ai Agents for Vault CRM and PromoMats	12-03	CI
Veeva Announces Expanded Partnership with Roche	11-24	CI
Veeva Systems Expands Partnership With Roche Pharmaceuticals	11-24	MT
Top Midday Stories: Lilly Becomes First Pharma Company to Hit $1 Trillion Market Cap; Enviri to Sell Clean Earth to Veolia for $3.04 Billion	11-21	MT
Sector Update: Health Care Stocks Rise Pre-Bell Friday	11-21	MT
Veeva Systems Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Fiscal 2026 Guidance Lifted	11-20	MT
(VEEV) Veeva Systems Expects Fiscal 2026 Non-GAAP EPS of About $7.93, vs. FactSet Est of $7.81	11-20	MT
(VEEV) Veeva Systems Inc. Expects Q4 Revenue Range $807.0M - $810.0M	11-20	MT
(VEEV) Veeva Systems Expects Fiscal 2026 Revenue Range $3.166B-$3.169B, vs. FactSet Est of $3.14B	11-20	MT
Earnings Flash (VEEV) Veeva Systems Inc. Reports Q3 Revenue $811.2M, vs. FactSet Est of $792.8M	11-20	MT
Earnings Flash (VEEV) Veeva Systems Inc. Posts Q3 Adjusted EPS $2.04 per Share, vs. FactSet Est of $1.95	11-20	MT
Veeva Systems Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ending January 31, 2026 and Updates Earnings Guidance for the Fiscal Year Ending January 31, 2026	11-20	CI
Veeva Systems Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2025	11-20	CI
Openevidence and Veeva announce Open Vista partnership	10-16	RE
Veeva Systems Insider Sold Shares Worth $4,378,500, According to a Recent SEC Filing	10-03	MT
Veeva Systems says Bristol Myers Squibb commits to Veeva Vault CRM	09-22	RE
Gilead Sciences Commits to Veeva Vault Crm	09-10	CI
Veeva Systems Expands Partnership With Gilead Sciences	09-10	MT
Veeva Systems' Guidance Boost Draws Mixed Investor Response Despite Q2 Beat, Oppenheimer Says	08-28	MT
Veeva Systems, Amgen Collaborate to Further Streamline Clinical Trials	08-28	MT
Veeva Systems Fiscal Q2 Non-GAAP Earnings, Revenue Rise; Fiscal 2026 Guidance Lifted	08-27	MT
Veeva Q2 revenue, adjusted net income beats estimates	08-27	RE
(VEEV) Veeva Systems Inc. Expects Q3 Revenue Range $790.0M - $793.0M	08-27	MT
(VEEV) Veeva Systems Inc. Expects Q3 Adjusted EPS Range $1.94 - $1.95	08-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Veeva MedTech adoption boosts clinical trials

July 09, 2025 at 01:03 am